A detailed history of California State Teachers Retirement System transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 96,642 shares of VKTX stock, worth $7.04 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
96,642
Previous 86,805 11.33%
Holding current value
$7.04 Million
Previous $7.12 Million 28.04%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$47.39 - $80.2 $466,175 - $788,927
9,837 Added 11.33%
96,642 $5.12 Million
Q1 2024

May 15, 2024

SELL
$17.4 - $94.5 $82,928 - $450,387
-4,766 Reduced 5.2%
86,805 $7.12 Million
Q4 2023

Feb 13, 2024

SELL
$9.24 - $19.64 $83,649 - $177,800
-9,053 Reduced 9.0%
91,571 $1.7 Million
Q3 2023

Nov 14, 2023

SELL
$10.92 - $16.0 $159,486 - $233,680
-14,605 Reduced 12.67%
100,624 $1.11 Million
Q2 2023

Aug 21, 2023

BUY
$14.84 - $24.79 $810,204 - $1.35 Million
54,596 Added 90.04%
115,229 $1.87 Million
Q1 2023

May 09, 2023

BUY
$8.08 - $17.33 $489,914 - $1.05 Million
60,633 New
60,633 $1.01 Million
Q2 2022

Aug 15, 2022

SELL
$2.11 - $3.15 $187,277 - $279,584
-88,757 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$3.0 - $4.88 $22,605 - $36,770
-7,535 Reduced 7.83%
88,757 $266,000
Q4 2021

Feb 15, 2022

BUY
$4.6 - $6.72 $10,267 - $14,999
2,232 Added 2.37%
96,292 $443,000
Q3 2021

Nov 15, 2021

SELL
$5.58 - $7.04 $2,137 - $2,696
-383 Reduced 0.41%
94,060 $591,000
Q2 2021

Aug 16, 2021

SELL
$5.19 - $6.73 $22,970 - $29,786
-4,426 Reduced 4.48%
94,443 $566,000
Q1 2021

May 18, 2021

SELL
$5.74 - $9.67 $4,695 - $7,910
-818 Reduced 0.82%
98,869 $625,000
Q1 2020

May 13, 2020

BUY
$3.45 - $7.95 $3,984 - $9,182
1,155 Added 1.17%
99,687 $467,000
Q4 2019

Feb 14, 2020

SELL
$6.38 - $8.73 $16,485 - $22,558
-2,584 Reduced 2.56%
98,532 $790,000
Q3 2019

Nov 15, 2019

BUY
$6.55 - $8.6 $7,905 - $10,380
1,207 Added 1.21%
101,116 $696,000
Q2 2019

Aug 14, 2019

BUY
$7.67 - $10.63 $46,311 - $64,183
6,038 Added 6.43%
99,909 $829,000
Q4 2018

Feb 13, 2019

BUY
$7.16 - $16.21 $104,077 - $235,628
14,536 Added 18.32%
93,871 $718,000
Q3 2018

Nov 14, 2018

BUY
$9.7 - $19.65 $123,151 - $249,476
12,696 Added 19.05%
79,335 $1.38 Million
Q2 2018

Aug 14, 2018

BUY
$3.88 - $12.74 $258,559 - $848,980
66,639 New
66,639 $632,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.59B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.